ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Robert J. Korst
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korst, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korst, R. J.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2006;82:248
© 2006 The Society of Thoracic Surgeons

Original article: General thoracic

Invited commentary

Robert J. Korst, MD

Weill Medical College of Cornell University, 525 East 68th St, New York, NY 10021

(Email: rjk2002@med.cornell.edu).

The first 20% of the full text of this article appears below.

NF-{kappa}B represents a small family of protein dimers, which when activated will act as DNA transcriptional regulators. Although originally believed to exert its regulatory effects on genes involved in immunologic and inflammatory processes, it is now understood that NF-{kappa}B induces the transcription of other genes, potentially involved in oncogenesis. The end result is that NF-{kappa}B activation . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.